Patents by Inventor Mi Sun LIM

Mi Sun LIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for producing pluripotent stem cell-derived spherical neural mass having suppressed teratoma formation
    Patent number: 11898164
    Abstract: Disclosed is a method for producing a spherical neural mass having suppressed teratoma formation. When using the spherical neural mass produced according to the method of the present disclosure, the purity of the neuronal progenitor cells may be improved, the teratoma formation may be suppressed, and the viability and recovery percentage of the cell may be increased.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: February 13, 2024
    Assignee: S.BIOMEDICS CO., LTD.
    Inventors: Myung Soo Cho, Mi Sun Lim, So Yeon Ji
  • METHOD FOR SUPPORTING AGENT AND COMPUTING DEVICE THEREOF
    Publication number: 20220129491
    Abstract: According to the present disclosure, an agent support method including acquiring information on or regarding at least one keyword related to counseling, identifying information on or regarding an index corresponding to the at least one keyword, and displaying a title related to a counseling record and an answer content list related to the index based on the information on the index and a computing device thereof is provided.
    Type: Application
    Filed: January 22, 2021
    Publication date: April 28, 2022
    Inventors: Jeong Hun Lee, Hye Jin Kim, Cho Rong Kim, Mi Sun Lim, Yoo Jung Jo, Eun Sol Kim, So Yeon Son, Sang Gwee Bae, Han Na Kang
  • METHOD FOR PRODUCING PLURIPOTENT STEM CELL-DERIVED SPHERICAL NEURAL MASS HAVING SUPPRESSED TERATOMA FORMATION
    Publication number: 20190330590
    Abstract: Disclosed is a method for producing a spherical neural mass having suppressed teratoma formation. When using the spherical neural mass produced according to the method of the present disclosure, the purity of the neuronal progenitor cells may be improved, the teratoma formation may be suppressed, and the viability and recovery percentage of the cell may be increased.
    Type: Application
    Filed: December 20, 2017
    Publication date: October 31, 2019
    Applicant: JEIL PHARMACEUTICAL CO., LTD.
    Inventors: Myung Soo CHO, Mi Sun LIM, So Yeon JI